Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center Identifier:
First received: September 28, 2010
Last updated: March 18, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):